Explore more publications!

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on December 29, 2025

The Better Brain Company’s Dementia Prevention Expert Dr. Clint Steele Releases “101 Brain Hacks To Prevent and Even Reverse Dementia”
MEDIROM Partners with World on Technology Envisioned  by Sam Altman and Alex Blania: Deploying “Proof of Human” Infrastructure throughout Japan
Genmab Portfolio Prioritization Update
BiomX Announces $3.0 Million Private Placement
Inspire Medical Systems, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA
neffy® (epinephrine nasal spray) Approved in China as the First and Only Community Use Epinephrine Product for the Treatment of Allergic Reactions (anaphylaxis)
Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering
AI In Medical Diagnostics Market In 2029
Suture Laparoscopic Forceps Market In 2029
Vital Parameter Monitoring Devices And Equipment Market In 2029
Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC)
Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet
Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production
Indaptus Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions